1. Genetic Screenings for Studying Bacterial Pathogenesis Dongwoo Shin, Ph.D. Associate Professor, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine

2. Structure of a Bacterial Cell

3. What is a pathogen? -An organism capable of colonizing a host organism where the interaction results in disease -opportunistic pathogens -strict pathogens

4. Opportunistic pathogens - Most of infections - Normal microbiota for causing disease - No disease in normal setting but disease when introduced into unprotected sites (e.g. blood, tissues) - Immunocompromised patients are more susceptible Staphylococcus aureus Escherichia coli Strict pathogens - A few infections Mycobacterim tuberculosis (tuberculosis) Neisseria gonorrhoeae (gonorrhea)

5. Exposure of an individual to an organism 1.Transient (hours or days) colonization 2.Permanent colonization 3.Disease production (Infection) [NOTE] Colonization vs. Infection

6. In a healthy human, - The internal tissues (e.g. brain, blood, muscles): normally free of microorganisms - Conversely, the surface tissues (e.g. skin and mucous membrane): constantly in contact with environmental microorganisms and become colonized by certain microbial species - Normal microbiota (= microflora, normal flora): mixture of microorganisms regularly found at any anatomical site - Bacteria make up most of the normal microbiota over the fungi and protozoa [NOTE] Normal microbiota (microflora)

7. What is virulence (pathogenicity)? -The capacity of a pathogen to cause damage or disease in the host -Virulence factors: Cell wall components (LPS, LTA), DNA, Proteins

9. Lipopolysacchride (LPS) -Somatic O polysacchride + Core polysaccharide + Lipid A

10. What is virulence (pathogenicity)? -The capacity of a pathogen to cause damage or disease in the host -Virulence factors: Cell wall components, DNA, Proteins

12. Bacteria and Disease Establishing connection: Koch’s Postulates Proving cause and effect in infectious disease research First raised in the 1800s by Robert Koch Koch’s postulates -association of the bacteria with the lesions of the disease -isolating the bacterium in pure culture -showing that the isolated bacterium causes disease in humans or animals -reisolating the bacterium from the intentionally infected animal

13. Establishing connection: Molecular Koch’s Postulates Raised in the 1988 by Stanley Falkow Molecular Koch’s postulates -gene (or its product) should be found only in strains of bacteria that cause the disease -gene should be “isolated” by cloning -disruption of gene in virulent strain should reduce virulence -gene is expressed by bacterium during infectious process in animal or human Bacteria and Disease

14. Identification of bacterial virulence factors 1.Understanding the molecular strategies used by a pathogen during host infection 2.Providing the targets in development of novel therapeutics for bacterial infection -Currently used antibiotics → Targeting bacterial viability → Selective pressure -Antivirulence therapy

15. Salmonella Escherichia coli Shigella Salmonella enterica Salmonella bongori Enterobacteriaceae TyphimuriumEnteritidisTyphiParatyphi Serovars Gastroenteritis Systemic disease

16. Complex Lifestyle of Salmonella Soil, water, food Host: Humans and animals

17. Salmonella enterica serovar Typhimurium  A facultative intracellular pathogen  Infects millions of people worldwide every year resulting in ~500,000 deaths  Transmission via contaminated food or water  Gastroenteritis (Human) and Typhoid fever (Mouse)  Serves as a model system for other intracellular pathogens

18. Biology of Salmonella Infection

19. “Environmental Signals inside Host” Expression of Necessary Proteins (Virulence Proteins) in the Correct Tissues Virulence Genes

20. Invasion into epithelial cells of small intestine Survival inside macrophages Systemic disease Stomach Type III Secretion Systems (TTSSs)

21. Expression of SPI-1 Genes Mediates Salmonella-Invasion into Host Cells Expression of ~30 genes in Salmonella Pathogenecity Island 1 (SPI-1) Type III Secretion System

22. SPI-1 TTSS-Induced Changes in Host Cells

23. Invasion into epithelial cells of small intestine Survival inside macrophages Systemic disease Stomach Type III Secretion Systems (TTSSs)

24. Phagosome-lysosome fusion ROS & RNS production Antimicrobial peptides Bacterial Killing Phagosome Bacterial killing processes inside phagosome

25. Salmonella Host cells effector proteins secretion system Induction of the SPI-2 T3SS within Macrophage

26. Alteration of vesicle trafficking LPS modification Preventing recruitment of NADH oxidase SPI-2 TTSS Phagosome Phagosome-lysosome fusion ROS & RNS production Antimicrobial peptides The SPI-2 T3SS prevents bacterial killing by macrophages

27. Genetic screenings of bacterial virulence factors 1.Pre-genomic era: 1990’s 2.Post-genomic era: 21C

28. In Vivo Expression Technology (IVET) 1.Isolation of Salmonella genes whose expression is induced inside the host (i.e. genes whose products are necessary for host infection) 2.Auxotrophic selection method (Science, 1993) and Differential fluorescence induction method (Science, 1997)

29. Auxotrophic selection method Step 1: Creating transcriptional fusions of random fragments of the Salmonella chromosome with promoterless purA and lacZ genes; introduction of this library into a purA mutant a mutant that cannot synthesize purines (auxotroph)

30. Auxotrophic selection method Step 2: Integration of a plasmid construct into chromosome of a purA mutant via single crossover

31. Auxotrophic selection method Step 3: Host infection with the pool of fusion strains and selection X-gal plate

32. Differential fluorescence induction (DFI) Rationale: trapping the gene promoters that are activated inside macrophages; using GFP macrophage Activation of mgtC transcription Salmonella PmgtC gfp

33. Differential fluorescence induction (DFI) Step 1: Cloning of random fragments of Salmonella chromosome into a promoterless gfp plasmid; introduction of plasmids into Salmonella

34. Differential fluorescence induction (DFI) Step 2: Infection of macrophages with Salmonella harboring gfp fusion plasmids; sorting GFP-active Salmonella with FACS

35. Validation of a screened candidate for virulence 1.In vitro method: Gentamicin protection assay for evaluations of Salmonella invasion into and survival within host cells 2.In vivo method: Animal experiments for evaluations of Salmonella’s ability to infect host

36. Validation of a screened candidate for virulence - Gentamicin protection assay: Infection of epithelial cells (e.g. Hep-2) or macrophages (e.g. J774.A) with Salmonella Incubation allowing for Salmonella to invade into epithelial cells or for macrophages to engulf Salmonella (i.e. phagocytosis) Gentamicin treatment to kill bacteria outside host cells Detergent treatment to lyse host cells; plating onto agar plate to count Salmonella

37. Validation of a screened candidate for virulence - Gentamicin protection assay: a mutant that cannot produce SPI-2 TTSS

38. Validation of a screened candidate for virulence - Animal experiments: Mouse infection model - Oral infection and Intraperitoneal infection - Immunocompromised mouse and Immunocompetent mouse

39. Validation of a screened candidate for virulence - Animal experiments:

40. Genetic screenings of bacterial virulence factors 1.Pre-genomic era: 1990’s 2.Post-genomic era: 21C

41. Announcement of Salmonella genome sequence: Nature (2000) “Now, one can predict which genes are important for Salmonella virulence and experimentally test them.”

42. In this paper, the authors evaluated the role of every single transcription factor (83 regulators) in Salmonella virulence

45. -A revolutionary method for construction gene deletion mutants in E. coli: PNAS (2000) -Applicable to other enteric bacteria: Salmonella, Klebsiella, Yersinia, Enterobacter etc. -Accurate, fast, and cheap method

47. Identification of 14 regulators required for Salmonella virulence